A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 1,558 shares of LLY stock, worth $1.29 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
1,558
Previous 1,543 0.97%
Holding current value
$1.29 Million
Previous $1.4 Million 1.22%
% of portfolio
0.48%
Previous 0.53%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $11,582 - $14,400
15 Added 0.97%
1,558 $1.38 Million
Q2 2024

Jul 17, 2024

BUY
$724.87 - $909.04 $156,571 - $196,352
216 Added 16.28%
1,543 $1.4 Million
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $592 - $792
1 Added 0.08%
1,327 $1.03 Million
Q4 2023

Jan 18, 2024

SELL
$525.19 - $619.13 $525 - $619
-1 Reduced 0.08%
1,326 $772,000
Q3 2023

Oct 13, 2023

SELL
$434.7 - $599.3 $76,941 - $106,076
-177 Reduced 11.77%
1,327 $712,000
Q1 2023

Apr 17, 2023

BUY
$310.63 - $364.82 $9,629 - $11,309
31 Added 2.1%
1,504 $516,000
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $32,155 - $37,467
100 Added 7.28%
1,473 $538,000
Q3 2022

Oct 12, 2022

BUY
$296.48 - $337.87 $7,412 - $8,446
25 Added 1.85%
1,373 $444,000
Q1 2022

Apr 29, 2022

BUY
$234.69 - $291.66 $4,693 - $5,833
20 Added 1.51%
1,348 $386,000
Q1 2021

Apr 22, 2021

BUY
$164.32 - $212.72 $218,216 - $282,492
1,328 New
1,328 $248,000
Q3 2020

Oct 14, 2020

SELL
$146.22 - $169.13 $233,952 - $270,608
-1,600 Closed
0 $0
Q1 2020

Apr 23, 2020

SELL
$119.05 - $147.35 $33,929 - $41,994
-285 Reduced 15.12%
1,600 $222,000
Q1 2020

Apr 16, 2020

BUY
$119.05 - $147.35 $33,929 - $41,994
285 Added 17.81%
1,885 $340,000
Q4 2019

Jan 29, 2020

BUY
$106.92 - $132.43 $171,072 - $211,888
1,600 New
1,600 $210,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cornell Pochily Investment Advisors, Inc. Portfolio

Follow Cornell Pochily Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornell Pochily Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornell Pochily Investment Advisors, Inc. with notifications on news.